N-ACETYL-DL-TRYPTOPHAN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C13H14N2O3
Molecular Weight	246.2619
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of N-ACETYL-DL-TRYPTOPHAN

Structure Search

SMILES

CC(=O)NC(CC1=CNC2=C1C=CC=C2)C(O)=O

InChI

InChIKey=DZTHIGRZJZPRDV-UHFFFAOYSA-N

InChI=1S/C13H14N2O3/c1-8(16)15-12(13(17)18)6-9-7-14-11-5-3-2-4-10(9)11/h2-5,7,12,14H,6H2,1H3,(H,15,16)(H,17,18)

HIDE SMILES / InChI

Molecular Formula	C13H14N2O3
Molecular Weight	246.2619
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: http://www.jbc.org/content/160/1/31.short | https://www.ncbi.nlm.nih.gov/pubmed/27987726 | https://www.ncbi.nlm.nih.gov/pubmed/27748798

Acetyltryptophan,DL- functions readily as a component of the food in place of the free amino acid - a greater amount of acetyltryptophane,DL- than dl-tryptophane may be available to man. Acetyltryptophan,DL- is used as an additive in the protein microbubbles, used in various biomedical applications such as contrast imaging, targeted drug and gene delivery, delivery of drugs through blood brain barrier (BBB) and IV O2 delivery etc. In the breast cancer biomarkers search, lower levels of endogenous metabolite Acetyltryptophan, DL- was identified in the fluid from the affected breasts compared to the control breast fluid.

Originator

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
release of cytochrome c from mitochondria 2 Target ID: GO:0001836 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18799679 \| https://www.ncbi.nlm.nih.gov/pubmed/26031348	Inhibitor 8297

Conditions

Conditions

Condition	Modality	Targets	Highest Phase	Product
Breast cancer 434 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27748798	Diagnostic		Not Provided 504	Unknown Approved Use Unknown

PubMed

PubMed

Title	Date	PubMed
N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis.	2015 Sep	26031348

Patents

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Incubation with Acetyltryptophan,DL- resulted in statistically significant inhibition of H2O2-mediated NSC-34 motoneuron cell death. The resulting curve (plotted semi-logarithmically) define the IC50 and maximum protection afforded by acetyltryptophan, DL- (1.0 uM and 22%, respectively).

Substance Class	Chemical Created by `admin` on `Sat Dec 16 07:43:56 GMT 2023` Edited by `admin` on `Sat Dec 16 07:43:56 GMT 2023`
Record UNII	4460NBV53F
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

N-ACETYL-DL-TRYPTOPHAN

Systematic Name

English

NSC-49124

Code

English

DL-ACETYLTRYPTOPHAN

Common Name

English

N-ACETYLTRYPTOPHAN

Systematic Name

English

ACETYLTRYPTOPHAN, DL- [II]

Common Name

English

Acetyltryptophan [WHO-DD]

Common Name

English

ACETYLTRYPTOPHAN, DL-

Common Name

English

N-ACETYLTRYPTOPHAN [EP MONOGRAPH]

Common Name

English

ACETYLTRYPTOPHAN

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C73539

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

Code System Code Type Description

EVMPD

SUB22284

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

CHEBI

70976

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

EVMPD

SUB12165MIG

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

FDA UNII

4460NBV53F

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

ECHA (EC/EINECS)

201-739-3

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

MESH

C006392

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

SMS_ID

100000085832

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

NCI_THESAURUS

C77305

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

RXCUI

1368212

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

RxNorm

DAILYMED

4460NBV53F

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

PUBCHEM

2002

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

CAS

87-32-1

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

EPA CompTox

DTXSID40861672

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

NSC

49124

Created by admin on Sat Dec 16 07:43:57 GMT 2023 , Edited by admin on Sat Dec 16 07:43:57 GMT 2023

PRIMARY

Related Record Type Details


					3EN9H0M2FX

N-ACETYL-DL-TRYPTOPHAN SODIUM

SALT/SOLVATE -> PARENT

Related Record Type Details


					C1LJO185Q9

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					TD4JN22JPS

(2S)-2-AMINO-3-(PHENYLAMINO)PROPANOIC ACID

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					7YO2KYD41V

2,3,4,9-TETRAHYDRO-1-(1H-INDOL-3-YLMETHYL)-1H-PYRIDO(3,4-B)INDOLE-3-CARBOXYLIC ACID

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					8DUH1N11BX

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					PS20W0733S

FORMYLKYNURENINE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					T82MWW5W3L

2-(2,3-DIHYDROXY-1-(1H-INDOL-3-YL)PROPYL)-L-TRYPTOPHAN

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					CK2W5X3J2K

1,2,3,4-TETRAHYDRO-BETA-CARBOLINE-3-CARBOXYLIC ACID

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					KW5HNG2EAV

DIOXYINDOLYLALANINE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					S9Q4BA8U8Q

2-(3-INDOLYLMETHYL)-L-TRYPTOPHAN

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					02JW4J5R44

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					TCB9GM9U3X

2-HYDROXYTRYPTOPHAN

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

Related Record Type Details


					4460NBV53F

N-ACETYL-DL-TRYPTOPHAN

ACTIVE MOIETY